Daily Alert – 2/21/19
This digital entertainment and e-commerce company is expected to grow at double-digit rates this quarter, boosting its shares’ momentum.
Read More
Emerging markets are economies whose gross domestic product (GDP) is growing at a much faster rate than more developed markets such as the U.S., Germany and Japan. Consequently, the stocks in those countries often grow at a faster clip than the average stock in a more mature market.
Brazil, Russia, India and China—the so-called “BRIC” nations—garner the most attention. But good stocks can be found in other, less populous corners of the globe, including South Korea, Mexico, Turkey, Saudi Arabia and South Africa. The options are numerous for investors willing to explore outside their American bubble.
There are myriad reasons to do so. Investing in emerging markets allows you to invest in countries with double-digit GDP growth—or close to it. At a time when America’s economy is expanding in the low single digits, Japan’s economy is struggling and much of Europe is still buried under a mountain of sovereign debt, emerging markets hold more appeal than ever.
Of course, all emerging markets investing comes with its fair share of risk. The term emerging is really a euphemism for “underdeveloped.”
Many emerging markets are plagued by political instability, inferior infrastructure, volatile currencies and limited equity opportunities. In addition, some of the largest companies in emerging markets are either state-run or private. There are simply more unknowns when investing in a market that is still developing. And the less you know about a company, the more risk you take on when you invest in it.
One way to curb the risk is to invest in American Depository Receipts (ADRs) traded on U.S. exchanges, which subjects the stocks to strict U.S. requirements.
For some, emerging markets are simply too risky. But for many, the potential for massive rewards is worth the extra risk.
This digital entertainment and e-commerce company is expected to grow at double-digit rates this quarter, boosting its shares’ momentum.
Read More
MedTech Stocks: Stable, Yet Defensive Growth
Medical technology, or MedTech, stocks, have long been a favorite for growth investors due to the attractive qualities of gradual, long-term growth in a relatively defensive industry. Throw in M&A potential and it’s not hard to see why group...
Read More
The shares of this payment company were recently initiated by Jefferies with a ‘Buy’ rating and were upgraded by UBS to ‘Buy’
Read More
I have always admired large blue chip stocks. They are tremendous organizations, full of executive talent and with tentacles spread out all over the world. Doors open for their CEOs wherever they go, from the corridors of power in New York or Washington overseas...
Read More
The market remains strong and I continue to recommend that you be heavily invested in a well-diversified portfolio that meets your investment needs.
Read More
Cabot Weekly Review (Video)
In this week’s stock market video, Mike Cintolo discusses the continuing market uptrend, though isn't complacent when it comes to a couple of worries (some resistance, many stocks extended from good entry points, etc.). The key now is to focus some...
Read More
Cabot Weekly Review (Video)
In this week’s stock market video, Mike Cintolo discusses the continuing market uptrend, though isn't complacent when it comes to a couple of worries (some resistance, many stocks extended from good entry points, etc.). The key now is to focus some...
Read More
U.S. stocks continue to defy gravity, with their audacious 2019 year-to-date gains mirroring their equally extreme fourth quarter 2018 descent.
Read More
From Cabot Top Ten Trader
The overall action from the major indexes and leading stocks remains about as good as you could hope for considering we’re two months off a major bottom—we’re nudging up our Market Monitor another notch (to 8) in this issue to the...
Read More
Small caps keep grinding higher. And many of the stocks in our portfolio are trading at, or near, all-time highs.
Read More
Our Emerging Markets Timer is still positive and constructive, though the EEM was essentially flat during the last week.
Read More
This list of the best investment sites to research stocks aims to help individual investors navigate the sea of stock-related information on the web.
Read More
Market Views
Caution Remains
Given that we’re fighting the 200-Day Moving Average; we can set-up for a bit of a pause. But it’s news-sensitive. So, for now, China may be a topic ‘beyond the interim pullback’ discussed as likely in February (or part of it, coming...
Read More
The market remains strong and I continue to recommend that you be heavily invested in a well-diversified portfolio that meets your investment needs.
Read More
U.S. stocks delivered great performance in January and are now taking a breather. As such, I expect the S&P 500 index to trade between 2625 and 2825 for a while. The trading range might end up being a little higher or a little but...
Read More
Cabot Weekly Review (Video)
In this week’s stock market video, Mike Cintolo discusses the continuing market uptrend, though isn't complacent when it comes to a couple of worries (some resistance, many stocks extended from good entry points, etc.). The key now is to focus some...
Read More
Cabot Weekly Review (Video)
In this week’s stock market video, Mike Cintolo discusses the continuing market uptrend, though isn't complacent when it comes to a couple of worries (some resistance, many stocks extended from good entry points, etc.). The key now is to focus some...
Read More
The market continues to look good as stocks are grinding higher with a few normal-looking down days mixed in (like yesterday) to keep investors honest. Average in, spread out your buys across different stocks, and take note of the current trading range and support,...
Read More
The sellers finally showed up today, with some negative headlines causing the market to pull back. In the Model Portfolio, we’re standing pat tonight with 35% in cash, though we’re spying a few names for possible new buying.
Read More
We’re not going to say emerging market stocks are showing any real strength, but there are a few encouraging signs out there—the iShares EM Fund (EEM) has stopped underperforming U.S. markets during the past couple of months, and even during the selloff of past...
Read More